Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Mupirocin Cream USP, 2%. Kumar Jeetendra | November 20, 2021 17th November 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mupirocin Cream USP, 2%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), …
Cipla launches Spirofy®: Strengthens its lung leadership position by facilitating early diagnosis for COPD1 Kumar Jeetendra | November 17, 2021 Mumbai, India; November 17, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced the launch of Spirofy®, India’s first pneumotach based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its …
Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index Kumar Jeetendra | November 15, 2021 Mumbai, India; November 15, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced today that it has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging Markets for 2021. The DJSI family of indices is operated by one of the world’s leading index providers S&P …
Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study Kumar Jeetendra | November 12, 2021 Hyderabad, Nov 12 (PTI) Bharat Biotech’s vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group, Phase III data published in The Lancet said on Friday.The efficacy data which was peer reviewed …
BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry Kumar Jeetendra | October 26, 2021 26 October 2021 – Life Science Newswire – BioPharma Dynamics, a leading life sciences solution provider, proudly announce the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester. This expansion sees the company treble in size, with its new premises adding the capacity for product assembly and …
Alembic Pharma gets EIR from USFDA for Karakhadi office Kumar Jeetendra | October 13, 2021 Drug firm Alembic Pharmaceuticals on Monday said it has received establishment inspection report (EIR) from the US health regulator for its new injectable facility at Karakhadi in Gujarat. The company has, ”received EIR from US Food and Drug Administration (USFDA) for the inspection carried out by them at our new injectable facility at Karakhadi during …
Lincoln Pharmaceuticals Ltd receives approval from Australian Regulator, TGA Kumar Jeetendra | October 9, 2021 Ahmedabad, October 8, 2021: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has received approval from Australia’s medicines and medical devices regulator – Therapeutic Goods Administration (TGA). Company’s manufacturing facility in Khatraj, Gujarat received the GMP clearance from TGA for all three departments Tablet, Capsule and Cream & Ointment, which will cover a wide …
Lupin gets speculative gesture from USFDA to market generic Brexpiprazole tablets Kumar Jeetendra | October 8, 2021 Drug firm Lupin on Wednesday said it has received tentative nod from the US health regulator to market generic Brexpiprazole tablets, which are used with anti-depressant medicines for the treatment of major depressive disorder, in the American market. The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market …
Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly’s key diabetes products Kumar Jeetendra | October 4, 2021 Mumbai, Oct 04 2021: Eli Lilly and Company (India) Pvt. Ltd. (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical company headquartered in Indianapolis, USA, and Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced its strategic partnership in …
Glenmark receives USFDA approval to market generic anti-biotic cream Kumar Jeetendra | September 22, 2021 Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Clindamycin Phosphate Foam, an antibiotic used for treating bacterial infections, in the American market. The Mumbai-based firm has received final approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Foam (1 per cent) which is …
Dr Reddy’s gets DCGI gesture to lead stage 3 trial of Sputnik Light in India Kumar Jeetendra | September 15, 2021 Dr Reddy’s Laboratories was granted approval by the drugs regulator to conduct Phase III trials of single-dose COVID-19 vaccination Sputnik Light. According to Hindustan Times, the subject expert committee (SEC), of the Central Drugs Standard Control Organisation CDSO (CDSO), had recommended to the Drugs Controller General of India(DCGI) that approval be granted to conduct Bridging …
Aleor Dermaceuticals gets USFDA gesture for generic antibacterial gel Kumar Jeetendra | September 13, 2021 Drug firm Alembic Pharmaceuticals on Monday said its joint venture Aleor Dermaceuticals has received approval from the US health regulator for generic Metronidazole gel, used in the treatment of inflammatory lesions of rosacea. Aleor Dermaceuticals Ltd has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) …
